Drugs / Semi-individualised Chinese Medicine treatment
Semi-individualised Chinese Medicine treatment
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02488252 | Jul 2015 → Mar 2021 | diabetic kidney disease | The University of Hong Kong | Unknown | Mixed |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Semi-individualised Chinese Medicine treatment | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02488252 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Chinese medicine (CM), a major form of traditional medicine used extensively in Asia” PMID 27496229 ↗ Aug 2016 |